Authors:
Máté Magyar Department of Neuroradiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary
Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary

Search for other papers by Máté Magyar in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0003-2589-9617
and
Kinga Kecskés Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary

Search for other papers by Kinga Kecskés in
Current site
Google Scholar
PubMed
Close
Open access

Abstract

Herpes zoster ophthalmicus is a viral infection caused by the varicella-zoster virus, affecting the ophthalmic branch of the trigeminal nerve, called the ophthalmic nerve. Herpes zoster ophthalmicus is characterized by a painful rash and blisters on one side of the forehead and around the eye, along with symptoms such as eye redness, tearing, and sensitivity to light, and can also lead to serious complications, such as corneal ulcers, glaucoma, and vision loss, particularly if the eye is involved. Herpes zoster myositis and oculomotor nerve involvement are rare complications of herpes zoster infection. Early diagnosis and treatment, such as antiviral medications, corticosteroids, and pain management, are important to prevent complications and to alleviate symptoms. In our case report we demonstrate the case of an 81-year-old female patient with left sided herpes zoster ophthalmicus, associated with MRI proved orbital myositis and oculomotor nerve involvement. Symptoms were slowly reduced with antiviral therapy. People who develop symptoms of herpes zoster ophthalmicus should seek prompt medical attention to receive appropriate care and to avoid serious complications.

Abstract

Herpes zoster ophthalmicus is a viral infection caused by the varicella-zoster virus, affecting the ophthalmic branch of the trigeminal nerve, called the ophthalmic nerve. Herpes zoster ophthalmicus is characterized by a painful rash and blisters on one side of the forehead and around the eye, along with symptoms such as eye redness, tearing, and sensitivity to light, and can also lead to serious complications, such as corneal ulcers, glaucoma, and vision loss, particularly if the eye is involved. Herpes zoster myositis and oculomotor nerve involvement are rare complications of herpes zoster infection. Early diagnosis and treatment, such as antiviral medications, corticosteroids, and pain management, are important to prevent complications and to alleviate symptoms. In our case report we demonstrate the case of an 81-year-old female patient with left sided herpes zoster ophthalmicus, associated with MRI proved orbital myositis and oculomotor nerve involvement. Symptoms were slowly reduced with antiviral therapy. People who develop symptoms of herpes zoster ophthalmicus should seek prompt medical attention to receive appropriate care and to avoid serious complications.

Introduction

Varicella zoster virus (VZV) reactivation can lead to vesicular rash eruption in the ophthalmic division of the trigeminal nerve, called herpes zoster ophthalmicus (HZO), a common ocular emergency [1]. In the literature, 7% of all cases of VZV infection present as HZO, of which 20–79% have orbital involvement [2]. VZV can affect almost all tissues located in the orbit, which includes the extra-ocular muscles, and can cause various forms of infection such as keratitis, scleritis, uveitis, ocular motor palsy, optic neuritis, or postherpetic neuralgia (PHN) [3]. Herpes zoster orbital myositis [4] and oculomotor nerve palsy [5] are rare conditions, occurring when the VZV reactivates in the nerves, controlling eye movement, leading to the inflammation of the extra-ocular muscles [4]. Symptoms typically include pain, double vision, and difficulty moving the eye. Diagnosis is typically made through a combination of physical exam, imaging studies, and laboratory tests [4, 6, 7]. Treatment options may include antiviral medications, corticosteroids, and supportive care [4]. Early recognition and timely medical management is important to prevent complications such as PHN and blindness [3].

Case presentation

An 81-year-old female patient suffering from left sided HZO for three weeks, progressively developed diplopia in all directions, with mydriasis and efferent pupillary defect. She had only hypertension and ischemic heart disease as chronic diseases.

Due to diplopia, contrast enhanced orbital MRI (Philips Ingenia 3 T, contrast material: Dotarem 10 ml) was requested, which revealed higher signal intensity on short tau inversion recovery (STIR) sequence in the left extraocular rectus muscles and of the intraorbital part of the left oculomotor nerve's lower division, corresponding to oedema. Mild contrast enhancement of the intraorbital part of the left oculomotor nerve's lower division was also observed on the fat suppressed (selective water excitation), contrast enhanced T1 weighted sequence (Figs 1 and 2). The radiological findings corresponded to both the left sided herpes zoster orbital myositis and oculomotor nerve involvement.

Fig. 1.
Fig. 1.

Coronal short tau inversion recovery (STIR) images. Consecutive slices depicting the swollen lower branch of the left oculomotor nerve with higher signal intensity compared to the other side (A). Swollen rectus muscles with higher signal intensity, compared to the other side (B). Arrow with continuous line: lower branch of the left oculomotor nerve. Arrow with dashed line: lower branch of the right oculomotor nerve. Arrow with dotted line: extraocular rectus muscles

Citation: Imaging 15, 1; 10.1556/1647.2023.00110

Fig. 2.
Fig. 2.

Coronal, fat suppressed (selective water excitation), contrast enhanced T1 weighted image. Consecutive slices (A, B) depicting swollen and contrast enhancing lower branch of the left oculomotor nerve, and the normal lower branch of the right oculomotor nerve. Arrow with continuous line: lower branch of the left oculomotor nerve. Arrow with dashed line: lower branch of the right oculomotor nerve

Citation: Imaging 15, 1; 10.1556/1647.2023.00110

Moderate lymphocytic pleiocytosis was detected by cerebrospinal fluid (CSF) examination, as an indirect result of VZV infection, but VZV was not detected in the CSF by PCR (the multiplex-CSF PCR did not confirm any other pathogen either). Steroid administration was not necessary, while local-, and acyclovir treatment was completed under observation. The patient had particularly severe complaints of PHN, therefore, pregabalin treatment was started in a slowly building up dose.

After emission, following up on an outpatient basis, the patient's complaints and symptoms improved significantly.

Discussion

Herpes zoster orbital myositis [4] and oculomotor nerve palsy [5] are rare, but potentially serious complications of HZO. Symptoms of herpes zoster orbital myositis typically include pain and swelling around the eye, double visions, droopy eyelid, which can be very distressing and can have a significant impact on a person's quality of life [8, 9]. Additionally, if left untreated, herpes zoster infection can lead to permanent eye damage and vision loss [3]. Diagnosis can be challenging, requires a thorough evaluation by an ophthalmologist, neurologist and often imaging studies, such as an MRI [10]. Once, a diagnosis of herpes zoster ophthalmicus is confirmed, treatment typically involves a combination of antiviral medications to treat the underlying infection and corticosteroids to reduce inflammation and swelling [7]. In our case report, an 81-year-old female patient suffered from left sided HZO, which was complicated with a left sided orbital myositis, oculomotor nerve involvement (confirmed by MR imaging) and PHN. The patient's complaints and symptoms improved with complex therapy.

Conclusions

HZO is a common ocular emergency, which is rarely associated with herpes zoster orbital myositis and oculomotor nerve palsy. Early diagnosis and prompt treatment is crucial to prevent permanent eye damage and vision loss. MR imaging seems to be recommended in such ocular cases of HZO to be quite sure about the extension of the disease.

Authors’ contribution

All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, including participation in the development of concept, writing, or revision of the manuscript. Acquisition of images: MM, KK. Analysis and/or interpretation of literature: MM, KK. Drafting the manuscript: MM, KK. Revising the manuscript critically for important intellectual content: MM, KK. Approval of the version of the manuscript to be published: MM, KK. This manuscript has not been published previously and is not under consideration for publication elsewhere.

Ethical statement

The study submitted to IMAGING have been conducted in accordance with the Declaration of Helsinki and according to requirements of all applicable local and international standards.

Funding sources

No financial support was received for this case report.

Conflict of interests

The authors have no conflict of interest to disclose.

References

  • [1]

    Borkar D, Tham V, Esterberg E, Ray K, Vinoya A, Parker J, et al.: Incidence of herpes zoster ophthalmicus: Results from the pacific ocular inflammation study. Ophthalmology 2013; 120(3): 451465.

    • Search Google Scholar
    • Export Citation
  • [2]

    McCrary M, Severson J, Tyring S: Varicella zoster virus. J Am Acad Dermatol. 1999; 41(1): 114.

  • [3]

    Vrcek I, Choudhury E, Durairaj V: Herpes Zoster ophthalmicus: a review for the internist. Am J Med. 2017; 130(1): 2126.

  • [4]

    Pereira A, Zhang A, Maralani P, Sundaram A: Acute orbital myositis preceding vesicular rash eruption in herpes zoster ophthalmicus. Can J Ophthalmol. 2020; 55(3): 107109.

    • Search Google Scholar
    • Export Citation
  • [5]

    Osman S: Successful oral treatment of third cranial nerve palsy and optic neuritis from neglected herpes zoster in an immunocompetent patient. Am J Ophthalmol Case Rep. 2020; 20: 100953.

    • Search Google Scholar
    • Export Citation
  • [6]

    Chen T: Orbital myositis with herpes zoster ophthalmicus. Pract Neurol. 2021; 002870.

  • [7]

    Dworkin R, Johnson R, Breuer J, Gnann J, Levin M, Backonja M, et al.: Recommendations for the management of herpes zoster. Clin Infect Dis. 2007; 44(Suppl 1): S1S6.

    • Search Google Scholar
    • Export Citation
  • [8]

    Conrady C, Feist R, Crum A: Shingles as the underlying cause of orbital myositis in an adolescent: a case report. Am J Ophthalmol Case Rep. 2016; 5: 111113.

    • Search Google Scholar
    • Export Citation
  • [9]

    Mizukami A, Sato K, Adachi K, Matthews S, Holl K, Matsuki T, et al.: Impact of herpes Zoster and post-herpetic neuralgia on health-related quality of life in Japanese adults aged 60 Years or older: results from a prospective, observational cohort study. Clin Drug Investig. 2018; 38(1): 2937.

    • Search Google Scholar
    • Export Citation
  • [10]

    Freund P, Chen S: Herpes zoster ophthalmicus. CMAJ 2018; 190(21): E656.

  • [1]

    Borkar D, Tham V, Esterberg E, Ray K, Vinoya A, Parker J, et al.: Incidence of herpes zoster ophthalmicus: Results from the pacific ocular inflammation study. Ophthalmology 2013; 120(3): 451465.

    • Search Google Scholar
    • Export Citation
  • [2]

    McCrary M, Severson J, Tyring S: Varicella zoster virus. J Am Acad Dermatol. 1999; 41(1): 114.

  • [3]

    Vrcek I, Choudhury E, Durairaj V: Herpes Zoster ophthalmicus: a review for the internist. Am J Med. 2017; 130(1): 2126.

  • [4]

    Pereira A, Zhang A, Maralani P, Sundaram A: Acute orbital myositis preceding vesicular rash eruption in herpes zoster ophthalmicus. Can J Ophthalmol. 2020; 55(3): 107109.

    • Search Google Scholar
    • Export Citation
  • [5]

    Osman S: Successful oral treatment of third cranial nerve palsy and optic neuritis from neglected herpes zoster in an immunocompetent patient. Am J Ophthalmol Case Rep. 2020; 20: 100953.

    • Search Google Scholar
    • Export Citation
  • [6]

    Chen T: Orbital myositis with herpes zoster ophthalmicus. Pract Neurol. 2021; 002870.

  • [7]

    Dworkin R, Johnson R, Breuer J, Gnann J, Levin M, Backonja M, et al.: Recommendations for the management of herpes zoster. Clin Infect Dis. 2007; 44(Suppl 1): S1S6.

    • Search Google Scholar
    • Export Citation
  • [8]

    Conrady C, Feist R, Crum A: Shingles as the underlying cause of orbital myositis in an adolescent: a case report. Am J Ophthalmol Case Rep. 2016; 5: 111113.

    • Search Google Scholar
    • Export Citation
  • [9]

    Mizukami A, Sato K, Adachi K, Matthews S, Holl K, Matsuki T, et al.: Impact of herpes Zoster and post-herpetic neuralgia on health-related quality of life in Japanese adults aged 60 Years or older: results from a prospective, observational cohort study. Clin Drug Investig. 2018; 38(1): 2937.

    • Search Google Scholar
    • Export Citation
  • [10]

    Freund P, Chen S: Herpes zoster ophthalmicus. CMAJ 2018; 190(21): E656.

  • Collapse
  • Expand

 

The author instruction is available in PDF.
Please, download the file from HERE.
 
The Open Access statement together with the description of the Copyright and License Policy are available in PDF.
Please, download the file from HERE.


 

Chair of the Editorial Board:
Béla MERKELY (Semmelweis University, Budapest, Hungary)

Editor-in-Chief:
Pál MAUROVICH-HORVAT (Semmelweis University, Budapest, Hungary)

Deputy Editor-in-Chief:
Viktor BÉRCZI (Semmelweis University, Budapest, Hungary)

Executive Editor:
Charles S. WHITE (University of Maryland, USA)

Deputy Editors:
Gianluca PONTONE (Department of Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy)
Michelle WILLIAMS (University of Edinburgh, UK)

Senior Associate Editors:
Tamás Zsigmond KINCSES (University of Szeged, Hungary)
Hildo LAMB (Leiden University, The Netherlands)
Denisa MURARU (Istituto Auxologico Italiano, IRCCS, Milan, Italy)
Ronak RAJANI (Guy’s and St Thomas’ NHS Foundation Trust, London, UK)

Associate Editors:
Andrea BAGGIANO (Department of Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy)
Fabian BAMBERG (Department of Radiology, University Hospital Freiburg, Germany)
Péter BARSI (Semmelweis University, Budapest, Hungary)
Theodora BENEDEK (University of Medicine, Pharmacy, Sciences and Technology, Targu Mures, Romania)
Ronny BÜCHEL (University Hospital Zürich, Switzerland)
Filippo CADEMARTIRI (SDN IRCCS, Naples, Italy) Matteo CAMELI (University of Siena, Italy)
Csilla CELENG (University of Utrecht, The Netherlands)
Edit DÓSA (Semmelweis University, Budapest, Hungary)
Marco FRANCONE (La Sapienza University of Rome, Italy)
Viktor GÁL (OrthoPred Ltd., Győr, Hungary)
Alessia GIMELLI (Fondazione Toscana Gabriele Monasterio, Pisa, Italy)
Tamás GYÖRKE (Semmelweis Unversity, Budapest)
Fabian HYAFIL (European Hospital Georges Pompidou, Paris, France)
György JERMENDY (Bajcsy-Zsilinszky Hospital, Budapest, Hungary)
Pál KAPOSI (Semmelweis University, Budapest, Hungary)
Mihaly KÁROLYI (University of Zürich, Switzerland)
Lajos KOZÁK (Semmelweis University, Budapest, Hungary)
Mariusz KRUK (Institute of Cardiology, Warsaw, Poland)
Zsuzsa LÉNARD (Semmelweis University, Budapest, Hungary)
Erica MAFFEI (ASUR Marche, Urbino, Marche, Italy)
Robert MANKA (University Hospital, Zürich, Switzerland)
Saima MUSHTAQ (Cardiology Center Monzino (IRCCS), Milan, Italy)
Gábor RUDAS (Semmelweis University, Budapest, Hungary)
Balázs RUZSICS (Royal Liverpool and Broadgreen University Hospital, UK)
Christopher L SCHLETT (Unievrsity Hospital Freiburg, Germany)
Bálint SZILVESZTER (Semmelweis University, Budapest, Hungary)
Richard TAKX (University Medical Centre, Utrecht, The Netherlands)
Ádám TÁRNOKI (National Institute of Oncology, Budapest, Hungary)
Dávid TÁRNOKI (National Institute of Oncology, Budapest, Hungary)
Ákos VARGA-SZEMES (Medical University of South Carolina, USA)
Hajnalka VÁGÓ (Semmelweis University, Budapest, Hungary)
Jiayin ZHANG (Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China)

International Editorial Board:

Gergely ÁGOSTON (University of Szeged, Hungary)
Anna BARITUSSIO (University of Padova, Italy)
Bostjan BERLOT (University Medical Centre, Ljubljana, Slovenia)
Edoardo CONTE (Centro Cardiologico Monzino IRCCS, Milan)
Réka FALUDI (University of Szeged, Hungary)
Andrea Igoren GUARICCI (University of Bari, Italy)
Marco GUGLIELMO (Department of Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Milan, Italy)
Kristóf HISRCHBERG (University of Heidelberg, Germany)
Dénes HORVÁTHY (Semmelweis University, Budapest, Hungary)
Julia KARADY (Harvard Unversity, MA, USA)
Attila KOVÁCS (Semmelweis University, Budapest, Hungary)
Riccardo LIGA (Cardiothoracic and Vascular Department, Università di Pisa, Pisa, Italy)
Máté MAGYAR (Semmelweis University, Budapest, Hungary)
Giuseppe MUSCOGIURI (Centro Cardiologico Monzino IRCCS, Milan, Italy)
Anikó I NAGY (Semmelweis University, Budapest, Hungary)
Liliána SZABÓ (Semmelweis University, Budapest, Hungary)
Özge TOK (Memorial Bahcelievler Hospital, Istanbul, Turkey)
Márton TOKODI (Semmelweis University, Budapest, Hungary)

Managing Editor:
Anikó HEGEDÜS (Semmelweis University, Budapest, Hungary)

Pál Maurovich-Horvat, MD, PhD, MPH, Editor-in-Chief

Semmelweis University, Medical Imaging Centre
2 Korányi Sándor utca, Budapest, H-1083, Hungary
Tel: +36-20-663-2485
E-mail: maurovich-horvat.pal@med.semmelweis-univ.hu

Indexing and Abstracting Services:

  • WoS Emerging Science Citation Index
  • Scopus
  • DOAJ

2022  
Web of Science  
Total Cites
WoS
65
Journal Impact Factor 0.4
Rank by Impact Factor

n/a

Impact Factor
without
Journal Self Cites
0.3
5 Year
Impact Factor
0.8
Journal Citation Indicator 0.06
Rank by Journal Citation Indicator

Medicine, General & Internal (Q4)

Scimago  
Scimago
H-index
18
Scimago
Journal Rank
0.171
Scimago Quartile Score

Medicine (miscellanous) (Q4)
Radiological and Ultrasound Technology (Q4)
Radiology, Nuclear Medicine and Imaging (Q4)

Scopus  
Scopus
Cite Score
1.0
Scopus
CIte Score Rank
Medicine (miscellaneous) 221/309 (28th PCTL)
Radiological and Ultrasound Technology 45/58 (23rd PCTL)
Radiology, Nuclear Medicine and Imaging 242/312 (22nd PCTL)
Scopus
SNIP
0.354

2021  
Web of Science  
Total Cites
WoS
56
Journal Impact Factor not applicable
Rank by Impact Factor

not applicable

Impact Factor
without
Journal Self Cites
not applicable
5 Year
Impact Factor
not applicable
Journal Citation Indicator 0,10
Rank by Journal Citation Indicator

Medicine, General & Internal 236/329

Scimago  
Scimago
H-index
16
Scimago
Journal Rank
0,226
Scimago Quartile Score Medicine (miscellaneous) (Q4)
Radiological and Ultrasound Technology (Q4)
Radiology, Nuclear Medicine and Imaging (Q4)
Scopus  
Scopus
Cite Score
1,6
Scopus
CIte Score Rank
Medicine (miscellaneous) 175/276 (Q3)
Radiology, Nuclear Medicine and Imaging 209/308 (Q3)
Radiological and Ultrasound Technology 42/60 (Q3)
Scopus
SNIP
0,451

2020  
CrossRef Documents 7
CrossRef Cites 0
CrossRef H-index 1
Days from submission to acceptance 17
Days from acceptance to publication 70
Acceptance Rate 43%

Imaging
Publication Model Gold Open Access
Submission Fee none
Article Processing Charge none
Subscription Information Gold Open Access

Imaging
Language English
Size A4
Year of
Foundation
2020 (2009)
Volumes
per Year
1
Issues
per Year
2
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2732-0960 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2023 0 126 46
Jul 2023 0 87 78
Aug 2023 0 52 58
Sep 2023 0 44 41
Oct 2023 0 41 26
Nov 2023 0 60 43
Dec 2023 0 0 0